Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Amortizatization of Intangibles (2022 - 2025)

Strata Critical Medical (SRTA) has disclosed Amortizatization of Intangibles for 4 consecutive years, with $482000.0 as the latest value for Q4 2025.

  • Quarterly Amortizatization of Intangibles fell 44.6% to $482000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, down 44.51% year-over-year, with the annual reading at $2.2 million for FY2025, 44.51% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $482000.0 at Strata Critical Medical, up from $224000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $1.8 million in Q4 2023, with the low at $224000.0 in Q3 2025.
  • Average Amortizatization of Intangibles over 4 years is $1.0 million, with a median of $823000.0 recorded in 2024.
  • The sharpest move saw Amortizatization of Intangibles skyrocketed 130.27% in 2023, then tumbled 72.78% in 2025.
  • Over 4 years, Amortizatization of Intangibles stood at $783000.0 in 2022, then surged by 130.27% to $1.8 million in 2023, then plummeted by 51.75% to $870000.0 in 2024, then tumbled by 44.6% to $482000.0 in 2025.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $482000.0, $224000.0, and $785000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.